Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

BC031181 Activators

BC031181 Activators are a diverse set of chemical compounds that influence the functional activity of the protein by modulating intracellular cyclic nucleotide levels, which are critical components of signaling pathways that BC031181 may be involved in. Forskolin, by directly activating adenylate cyclase, leads to increased intracellular cAMP, which could enhance BC031181 activity if it is part of the cAMP-dependent signaling pathways. Similarly, several phosphodiesterase inhibitors, including Rolipram, IBMX, and Anagrelide, contribute to elevated cAMP levels, providing a potential mechanism for the enhancement of BC031181 activity. Theophylline also functions in this capacity by non-selectively inhibiting phosphodiesterases, thus boosting cAMP levels and possibly augmenting BC031181 activity. In addition to cAMP, cGMP is another second messenger that can play a role in the activation of BC031181.

Compounds such as Zaprinast, YC-1, Sildenafil, Vardenafil, and Tadalafil act by inhibiting PDE5 or activating soluble guanylyl cyclase, leading to increased cGMP levels, which may potentiate BC031181 if it is cGMP-dependent. The modulation of cyclic nucleotide levels by these activators suggests a multifaceted approach to enhancing BC031181 activity through the fine-tuning of intracellular signaling dynamics. For instance, Milrinone and Dipyridamole, through selective and non-selective inhibition of phosphodiesterases, respectively, lead to an accumulation of cAMP, further offering a route to potentiate BC031181 if it is responsive to such signaling molecules.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

Rolipram inhibits phosphodiesterase 4 (PDE4), leading to increased cAMP levels, potentially enhancing BC031181 activity if it is regulated by cAMP.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP and cGMP levels, which may enhance BC031181 activity if it operates through these cyclic nucleotides.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$103.00
$245.00
8
(2)

Zaprinast inhibits PDE5, increasing cGMP levels, which could enhance BC031181 activity if it is cGMP-dependent.

YC-1

170632-47-0sc-202856
sc-202856A
sc-202856B
sc-202856C
1 mg
5 mg
10 mg
50 mg
$32.00
$122.00
$214.00
$928.00
9
(1)

YC-1 activates soluble guanylyl cyclase, increasing cGMP levels, which can potentiate BC031181 if it functions through cGMP signaling.

Dipyridamole

58-32-2sc-200717
sc-200717A
1 g
5 g
$30.00
$100.00
1
(1)

Dipyridamole is a phosphodiesterase inhibitor, which increases cAMP and cGMP levels, potentially enhancing BC031181 activity through these pathways.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$162.00
$683.00
7
(0)

Milrinone selectively inhibits PDE3, increasing cAMP levels, and could indirectly enhance BC031181 activity if it is cAMP-mediated.

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$516.00
$720.00
$16326.00
7
(1)

Vardenafil, a PDE5 inhibitor, increases cGMP levels, which may lead to enhanced BC031181 activity if it utilizes cGMP signaling.

Tadalafil

171596-29-5sc-208412
50 mg
$176.00
13
(2)

Tadalafil is a PDE5 inhibitor that elevates cGMP levels, potentially enhancing BC031181 activity if it is cGMP-dependent.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$31.00
$83.00
6
(0)

Theophylline, by inhibiting phosphodiesterases, increases cAMP levels, which could enhance BC031181 activity if it operates through cAMP-dependent pathways.